ShangPharma opens pilot plant in Shanghai

Published: 17-Jan-2011
Design & Build Manufacturing Regulatory Research & Development Cleaning Analysis Pharmaceutical

For pharma development and cGMP manufacturing

ShangPharma Corporation, a China-based contract research and manufacturing organisation, has started operations at a new manufacturing facility in the Shanghai suburb of Fengxian.

The new multi-purpose pharmaceutical development and cGMP manufacturing facility will allow ShangPharma to support its clients Phase II and Phase III trials, expanding its service offering to include process and formulation r&d, analytical method development and validation, and cGMP manufacturing of intermediates and APIs.

Previously the CRO/CMO provided clients with materials for early discovery and GLP toxicology testing and Phase I clinical trials.

ShangPharma said it might further expand its manufacturing facilities if there is demand for commercial manufacturing of FDA- or EMEA-approved drugs.

The Fengxian facility will operate as a wholly owned subsidiary of the company under the name China Gateway Pharmaceutical Development Co. It includes a pilot plant that supports six separate bays with reactor capacities ranging from 200 to 3,000 litres and other speciality bays with reactor capacities ranging from 50 to 2000 litres for high temperature, cryogenics, highly toxic and pressurised reactions, including hydrogenation.

The company said there are also two cleanroom suites rated at Class 100,000 for isolation, 10 kilo-lab suites for bothnon-cGMP and cGMP manufacturing, as well as a large r&d laboratory for analytical, formulation and process development activities.

In addition, there are separate buildings for utilities, materials management, warehouse storage and waste water treatment with room for further expansion to support commercial manufacturing activities.

Testing of raw materials, intermediates and final products will be carried out at the site. An independent quality assurance department will ensure that materials are manufactured in accordance with cGMP requirements and that established standard operating procedures are followed, the firm said.

See more

You may also like

Design & Build

SpaceX secures tax break for $55bn Terafab semiconductor facility

Read more
Texas officials have approved a 35-year tax incentive package for SpaceX’s proposed Terafab semiconductor manufacturing complex

Trending Articles

  1. FDA launches pilot of one-day “shorter” inspection assessments The US Food and Drug Administration (FDA) has launched a pilot programme introducing one-day inspectional assessments aimed at broadening regulatory oversight
  2. European Pharmacopoeia Issue 13.1 published with new and revised texts scheduled for January 2027 implementation The European Directorate for the Quality of Medicines & HealthCare (EDQM) has introduced new, revised and corrected general chapters, monographs and reagents
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Are centralised and de-centralised approaches to CGT manufacturing really that different? Andrew Scheffler from ScaleReady discusses whether CGT manufacturing should be centralised in large, industrial facilities, or decentralised closer to the patient in hospital-based or regional sites
  4. Designed for USP 797: Airkey's ISO 7 Modular Cleanroom for Sterile Compounding Airkey, a China-based cleanroom manufacturer, has successfully designed, factory-tested, and delivered a fully free-standing ISO 7 modular cleanroom for a sterile compounding customer in theUnitedStates.The project reflects the growing demand for turnkey, compliance-ready cleanroom solutions that can be installed quickly without extensive building modifications
  5. BES Limited BES provides specialist multi-disciplinary design, engineering, and construction solutions, exclusively serving the Pharmaceutical, Biotechnology, Life Sciences and Healthcare industries. We design and build complex facilities including cGLP and cGMP compliant laboratories, cleanrooms and containment suites respectively, for the discovery, development, manufacturing, packaging and logistics of life changing medicines and technologies

Upcoming event

CPhI South East Asia

08-10 July 2026 | Exhibition and Conference | Bangkok, Thailand See all

You may also like

Design & Build

SpaceX secures tax break for $55bn Terafab semiconductor facility

Texas officials have approved a 35-year tax incentive package for SpaceX’s proposed Terafab semiconductor manufacturing complex
Design & Build

Designed for USP 797: Airkey's ISO 7 Modular Cleanroom for Sterile Compounding

Airkey, a China-based cleanroom manufacturer, has successfully designed, factory-tested, and delivered a fully free-standing ISO 7 modular cleanroom for a sterile compounding customer in theUnitedStates.The project reflects the growing demand for turnkey, compliance-ready cleanroom solutions that can be installed quickly without extensive building modifications
Regulatory

European Pharmacopoeia Issue 13.1 published with new and revised texts scheduled for January 2027 implementation

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has introduced new, revised and corrected general chapters, monographs and reagents
Regulatory

FDA launches pilot of one-day “shorter” inspection assessments

The US Food and Drug Administration (FDA) has launched a pilot programme introducing one-day inspectional assessments aimed at broadening regulatory oversight
Design & Build

Guardware Cleanroom Hardware helping Life Sciences, Healthcare and High-Tech Engineering applications show their true colours

Guardtech’s furniture & equipment specialists are providing elite hardware solutions for some of the leading lights in ground-breaking science and engineering sectors
Containment

Elis Cleanroom wins Cleanroom Technology's Sustainability in Cleanroom Practices Award

The judge particularly valued the depth of analysis and the clear demonstration of reduced waste, lower water consumption, and overall lifecycle impact. This entry highlights how sustainability in cleanrooms can move beyond theory into measurable, actionable change
Design & Build

An ISO 5 Free-standing Cleanroom for 3D Printing: Airkey's Latest U.S. Project

Airkey, a China-based cleanroom manufacturer, has successfully designed, factory-tested, and delivered a fully free-standing ISO 5 modular cleanroom for a customer in the United States specialising in 3D printing for industries such as aerospace and medical industries
Subscribe now